BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lai Y, Feng B, Abudoureyimu M, Zhi Y, Zhou H, Wang T, Chu X, Chen P, Wang R. Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma. Front Oncol 2019;9:1156. [PMID: 31750247 DOI: 10.3389/fonc.2019.01156] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Hu S, Liu Y, Guan S, Qiu Z, Liu D. Natural products exert anti-tumor effects by regulating exosomal ncRNA. Front Oncol 2022;12:1006114. [DOI: 10.3389/fonc.2022.1006114] [Reference Citation Analysis]
2 Tian X, Yan T, Liu F, Liu Q, Zhao J, Xiong H, Jiang S. Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights. Front Pharmacol 2022;13:991052. [DOI: 10.3389/fphar.2022.991052] [Reference Citation Analysis]
3 Lu Q, Xin M, Guo Q, Rothberg BS, Gamero AM, Yang L. Knockdown of lncRNA TP53TG1 Enhances the Efficacy of Sorafenib in Human Hepatocellular Carcinoma Cells. ncRNA 2022;8:61. [DOI: 10.3390/ncrna8040061] [Reference Citation Analysis]
4 Ma T, Wu F, Wu H, Fa Q, Chen Y. Long Non-Coding RNA MCM3AP-AS1: A Crucial Role in Human Malignancies. Pathol Oncol Res 2022;28:1610194. [DOI: 10.3389/pore.2022.1610194] [Reference Citation Analysis]
5 Sun J, Zheng X, Wang B, Cai Y, Zheng L, Hu L, Lu X, Xie S, Zhang X, Liu H, Ye L. LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells. Acta Biochim Biophys Sin (Shanghai) 2022;54:261-70. [PMID: 35130616 DOI: 10.3724/abbs.2021019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lin Z, Ji X, Tian N, Gan Y, Ke L. Mapping Intellectual Structure for the Long Non-Coding RNA in Hepatocellular Carcinoma Development Research. Front Genet 2021;12:771810. [PMID: 35047004 DOI: 10.3389/fgene.2021.771810] [Reference Citation Analysis]
7 Ren H, Wei ZC, Sun YX, Qiu CY, Zhang WJ, Zhang W, Liu T, Che X. ATF2-Induced Overexpression of lncRNA LINC00882, as a Novel Therapeutic Target, Accelerates Hepatocellular Carcinoma Progression via Sponging miR-214-3p to Upregulate CENPM. Front Oncol 2021;11:714264. [PMID: 34513693 DOI: 10.3389/fonc.2021.714264] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Wang LT, Liu KY, Chiou SS, Huang SK, Hsu SH, Wang SN. Phosphorylation of intestine-specific homeobox by ERK1 modulates oncogenic activity and sorafenib resistance. Cancer Lett 2021;520:160-71. [PMID: 34265398 DOI: 10.1016/j.canlet.2021.07.011] [Reference Citation Analysis]
9 Liu J, Wei Y, Wang T, Zhang Z, Huang H, Wang C, Li H, Jia Q, Wu H, Zou T. The prognostic significance of long non-coding RNAs in hepatocellular carcinoma: An updated meta-analysis. Int J Biol Markers 2020;35:3-11. [PMID: 33208027 DOI: 10.1177/1724600820965579] [Reference Citation Analysis]
10 Gao S, Ni Q, Wu X, Cao T. GHR knockdown enhances the sensitivity of HCC cells to sorafenib. Aging (Albany NY) 2020;12:18127-36. [PMID: 32970612 DOI: 10.18632/aging.103625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
11 Liang Y, Liang Q, Qiao L, Xiao F. MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular Carcinoma. Front Oncol 2020;10:920. [PMID: 32695666 DOI: 10.3389/fonc.2020.00920] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
12 Manna D, Sarkar D. Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E1243. [PMID: 32429062 DOI: 10.3390/cancers12051243] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wang M, Yu F, Chen X, Li P, Wang K. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma. Mol Ther Nucleic Acids 2020;21:13-27. [PMID: 32505000 DOI: 10.1016/j.omtn.2020.05.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]